Neurosurgical Management of Brain Tumors: A Review of Treatment Protocols and Success Rates in Pakistan..
Keywords:
spine, orthopedics, endoscopic discectomy, lumbar disc prolapse, disc degenerative disease.Abstract
Background: Brain tumors represent one of the most challenging conditions in neurosurgery due to their complex anatomy, aggressive nature, and potential for significant neurological impairment. In Pakistan, the burden of brain tumors is increasing, while neurosurgical services face limitations in infrastructure, early diagnosis, and access to advanced treatment modalities. Despite these challenges, neurosurgical interventions remain the primary treatment modality for most brain tumors.
Objective: This review study aimed to evaluate neurosurgical management protocols for brain tumors in Pakistan and assess treatment outcomes, including surgical success rates, complications, and patient survival.
Material and Methods: A comprehensive review of hospital-based records and published literature from major neurosurgical centers in Pakistan was conducted. Data regarding patient demographics, tumor types, surgical techniques (craniotomy, stereotactic biopsy, and endoscopic procedures), adjuvant therapies, and postoperative outcomes were analyzed. Success rates were assessed based on extent of tumor resection, neurological improvement, complication rates, and survival outcomes.
Results: Gliomas and meningiomas were found to be the most common brain tumors treated surgically. Craniotomy with tumor excision was the most frequently performed procedure, followed by stereotactic biopsy in deep-seated lesions. Overall surgical success rates ranged from moderate to high depending on tumor type and location. Meningiomas showed better postoperative outcomes compared to high-grade gliomas. Complication rates included infection, neurological deficits, and postoperative edema. One-year survival was significantly higher in benign tumors, while malignant tumors demonstrated limited survival despite combined therapy.
Conclusion: Neurosurgical management of brain tumors in Pakistan demonstrates acceptable outcomes, particularly for benign lesions. However, challenges such as delayed presentation, limited resources, and advanced disease at diagnosis impact overall survival. Strengthening neurosurgical infrastructure and early diagnostic pathways is essential to improve treatment outcomes..
Downloads
References
[1] Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS statistical report: primary brain and other central nervous system tumors. Neuro Oncol. 2019;21(Suppl 5):v1–v100.
[2] Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system. Acta Neuropathol. 2021;142(4): 587–623.
[3] Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
[4] Weller M, van den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas. Lancet Oncol. 2021;22(6):e281–e291.
[5] Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753–764.
[6] DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114–123.
[7] Schwartz TH, Fehlings MG. Advances in neurosurgical techniques for brain tumors. Neurosurg Clin N Am. 2013;24(4):1–12.
[8] Black PM. Brain tumor surgery in the modern era. Lancet Neurol. 2012;11(2):123–134.
[9] Sughrue ME, Rutkowski MJ, Shangari G, et al. Meningioma outcomes after surgery. J Neurosurg. 2010;113(5):1029–1037.
[10] Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507.
[11] Patchell RA. The management of brain metastases. Oncologist. 2003;8(1):20–29.
[12] Sanai N, Laws ER. Neurosurgical techniques for tumor resection. Lancet Oncol. 2015;16:e143–e152.
[13] Stark AM, et al. Surgical management of brain tumors: outcomes and survival. Clin Neurol Neurosurg. 2012;114(7):941–949.
[14] McGirt MJ, Chaichana KL, Gathinji M, et al. Predictors of survival in brain tumor patients. Neurosurgery. 2009;65(5):1030–1037.
[15] Wick W, Platten M. Treatment of gliomas in the modern era. Nat Rev Neurol. 2018;14(4):221–232
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.